Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections (Q43289571)

From Wikidata
Jump to navigation Jump to search
scientific article published on 18 August 2009
edit
Language Label Description Also known as
English
Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections
scientific article published on 18 August 2009

    Statements

    Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections (English)
    Joseph Solomkin
    Yu-Pei Zhao
    En-Ling Ma
    Min-Jun Chen
    Barbara Hampel
    DRAGON Study Team
    18 August 2009
    439-445

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit